SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (121)9/30/1998 9:44:00 AM
From: Mike McFarland  Read Replies (1) | Respond to of 1073
 
there are certainly several such genes

The human genome has something like 10^9 nucleotide
pairs--how much of that which is functional is devoted
to the immune system, and of that how much for T cells,
and of that how much devoted to the CD4 protein?
No doubt this Chiroscience patent marks an important
discovery--now will they develop a way to manipulate
the gene? Probably somebody else will pay them for the
priveledge?

Three questions all in one shot! I am getting more
efficient, but hopefully not more annoying too :-)

--MM



To: scaram(o)uche who wrote (121)12/17/1998 5:31:00 PM
From: nigel bates  Read Replies (2) | Respond to of 1073
 
Rick,

any idea who might pick up Chiroscience's anaesthetic if the Astra Zeneca thing goes ahead ?

yahoo.co.uk

The stock did nothing despite approval of the compound. Worth another look ?

nig